Future Tech Jobs Future Tech Jobs

Senior Director, Search & Evaluation Ig TA Lead

CSL
3 months ago
Applications closed

Related Jobs

View all jobs
Spotlight

Senior Director Global Clinical Program Lead Cardiovascular & Renal

CSL
On-site

Senior Director, Search & Evaluation Ig TA Lead

CSL

Director, Search & Evaluation Early TA Lead

CSL

Director, Search & Evaluation Early TA Lead

CSL

Senior Director Global Clinical Program Lead Cardiovascular & Renal

CSL Switzerland
On-site

Senior Director, Global Product Lead, Early Oncology R&D

AstraZeneca Cambridge, United Kingdom
On-site
Seniority
Director
Posted
5 Feb 2026 (3 months ago)
Share
Save job
Create job alert

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we’re building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide.

Could you be our next Senior Director, Search & Evaluation Ig TA Lead? The job is in our Waltham MA, King of Prussia PA Office Maidenhead UK or Zurich Switzerland. This is a hybrid position and is onsite three days a week.

Position DescriptionSummary

Lead strategic sourcing and evaluation of external assets and technologies that enhance the administration and delivery of Immunoglobulin (Ig) products. This role will focus on identifying innovative formulation technologies, delivery devices, and enabling platforms that improve patient experience, optimize dosing, and strengthen our competitive position. The ideal candidate combines deep technical expertise with strong business development acumen and a proven ability to drive partnerships from early engagement through deal close.

MainResponsibilities &Accountabilities

  • Lead proactive sourcing efforts for technologies and assets across all stages of development that improve Immunoglobulin product administration, including advanced formulations, novel delivery devices, and patient-centric solutions.

  • Develop and execute partnering strategies for onboarding innovative technologies, creating competitive advantage and accelerating time-to-market.

  • Engage with external innovators, device manufacturers, and technology providers, building strong relationships and assessing strategic fit.

  • Drive cross-functional due diligence for selected opportunities, coordinating technical, regulatory, clinical, and commercial assessments to inform governance decisions.

  • Collaborate closely with BD leadership to advance high-priority opportunities through negotiation and deal close.

  • Represent the TA externally, leading sourcing activities at specialized conferences and fostering connections with technology networks and academic institutions.

Qualifications &ExperienceRequirements

  • 12+ years in biopharma or medical device industry with experience in external innovation, technology scouting, or business development.

  • Advanced degree required (PhD in Pharmaceutical Sciences and/or device relevant areas).

  • Deep expertise in formulation science, drug delivery technologies, and device platforms relevant to Immunoglobulin products.

  • Proven track record of structuring and closing technology partnerships.

  • Strong understanding of regulatory pathways and patient-centric design considerations.

#LI-HYBRID

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.


CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.

Our Benefits

For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.

You Belong at CSL

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging

Equal Opportunity Employer

CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.

Industry Insights

Discover insightful articles, industry insights, expert tips, and curated resources.

Products

Where to Advertise Biotech Jobs in the UK (2026 Guide)

Advertising biotech jobs in the UK requires a different approach to most technical hiring. The candidate pool spans life scientists, computational biologists, regulatory specialists and biomanufacturing engineers — each with distinct professional networks and job search behaviours. General job boards reach a broad audience but lack the specificity that biotech professionals expect. Specialist platforms, academic channels and sector-specific communities each serve a different part of the market. This guide, published by BiotechnologyJobs.co.uk, covers where to advertise biotech roles in the UK in 2026, how the main platforms compare, what employers should expect to pay, and what the data says about hiring across different role types.

Jobs

Biotech Jobs UK 2026: What to Expect Over the Next 3 Years

Biotechnology is creating jobs at a rate that few other sectors can match. New disciplines are emerging from research labs and entering commercial hiring pipelines, existing roles are fragmenting into deeper specialisms, and the technologies driving it all — from AI-assisted drug discovery to next-generation gene editing — are advancing faster than the workforce can keep pace with. For job seekers, this creates an unusual challenge. In most industries, career planning means navigating a relatively familiar landscape and identifying where your skills fit. In biotech, that landscape is being actively redrawn. The roles generating the most hiring activity in 2028 may look quite different from the ones appearing in job adverts today. That's not a reason to feel overwhelmed — it's a reason to get informed. The candidates who thrive in this market aren't always those with the longest CVs or the most letters after their name. They're the ones who understand where the sector is heading: which disciplines are gaining commercial traction, which technologies are driving employer demand, and how the definition of a "biotech job" is expanding well beyond traditional pharmaceuticals and research roles. This article breaks down what the UK biotech jobs market is likely to look like over the next three years — covering emerging job titles, the technologies reshaping hiring, the skills employers are prioritising right now, and how to position your career ahead of the curve rather than behind it.

Jobs

New Biotech Employers to Watch in 2026: UK and Global Companies Transforming Life Sciences Careers

The biotechnology job market in the UK is entering a new phase—one defined by scientific breakthroughs, targeted investment, and a growing pipeline of innovative employers. For professionals browsing BiotechnologyJobs.co.uk, the key question is no longer just which companies exist, but which ones are scaling, hiring, and shaping the future of life sciences. In this article, we explore the new biotech employers to watch in 2026, focusing on UK-based startups, scale-ups, and international firms with a growing UK presence. These organisations have recently secured funding, partnerships, or strategic backing—strong indicators of hiring momentum in the months ahead.

🍪 Basic, anonymous analytics (aggregate counts only, never shared) are always on. Accept to also enable third-party tools — Google Analytics, Microsoft Clarity, Mixpanel, Leadfeeder — which help us match you with relevant Biotechnology roles. We never sell your data or use it for cross-site advertising. See our Cookie Policy.